January 1, 2011Chemotherapy

Clinical and Electrocardiography Changes in Patients Treated with Capecitabine

View Full Paper

Ask AI

Bookmark

Why the study?

What is the incidence of cardiac events in cancer patients treated with capecitabine?

Population

52 patients with cancer, median age 59 years, treated at a Medical Oncology Clinic between 2009 and 2010.

Design

Cohort

Authors

DKDoğan KocaSağlık Bilimleri Üniversitesi TSTarık SalmanIzmir University İÜİlkay Tuğba ÜnekDokuz Eylül University

Discussion

Member takes

Implication

May support vigilant cardiac monitoring with capecitabine; leaves open optimal surveillance strategies.

Structured PICO

What is the incidence of cardiac events in cancer patients treated with capecitabine?

Population

52 patients with cancer, median age 59 years, treated at a Medical Oncology Clinic between 2009 and 2010.

Intervention

Capecitabine treatment (either single-agent or combination chemotherapy)

Outcome

Incidence of cardiac events (classified into cardiac symptoms, physical signs, electrocardiography findings, and severe adverse cardiac effects)safety

Capecitabine treatment is associated with a high incidence of cardiac events, including ECG changes and symptoms, warranting close cardiovascular monitoring.

Cite This Study

Koca et al. (2011) studied this question.

synapsesocial.com/papers/6a711cd3660549caf2c5beeb https://doi.org/10.1159/000331645

Topics

Women and heart disease

View Full Paper

Ask AI

Bookmark

January 1, 2011Chemotherapy

Clinical and Electrocardiography Changes in Patients Treated with Capecitabine

View Full Paper

Ask AI

Bookmark

Why the study?

What is the incidence of cardiac events in cancer patients treated with capecitabine?

Population

52 patients with cancer, median age 59 years, treated at a Medical Oncology Clinic between 2009 and 2010.

Design

Cohort

Authors

DKDoğan KocaSağlık Bilimleri Üniversitesi TSTarık SalmanIzmir University İÜİlkay Tuğba ÜnekDokuz Eylül University

Discussion

Member takes

Implication

May support vigilant cardiac monitoring with capecitabine; leaves open optimal surveillance strategies.

Structured PICO

What is the incidence of cardiac events in cancer patients treated with capecitabine?

Population

52 patients with cancer, median age 59 years, treated at a Medical Oncology Clinic between 2009 and 2010.

Intervention

Capecitabine treatment (either single-agent or combination chemotherapy)

Outcome

Incidence of cardiac events (classified into cardiac symptoms, physical signs, electrocardiography findings, and severe adverse cardiac effects)safety

Capecitabine treatment is associated with a high incidence of cardiac events, including ECG changes and symptoms, warranting close cardiovascular monitoring.

Cite This Study

Koca et al. (2011) studied this question.

synapsesocial.com/papers/6a711cd3660549caf2c5beeb https://doi.org/10.1159/000331645

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Topics

Women and heart disease

View Full Paper

Ask AI

Bookmark